ENOV
Enovis Corp
NYSE: ENOV · HEALTHCARE · MEDICAL DEVICES
$21.91
+1.72% today
Updated 2026-10-28
Market cap
$1.12B
P/E ratio
—
P/S ratio
0.49x
EPS (TTM)
$-19.23
Dividend yield
—
52W range
$17 – $34
Volume
1.6M
Enovis Corp (ENOV) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$21.91
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$34.64
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.6B | $1.7B | $2.1B | $2.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -48.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.